CLINICAL_TRIALS
trial_result
· 2020-10-20
Clinical Trial Update: Genomic Markers Before and After Treatment of Actinic Keratosis With Imiquimod 3.75% Cream [Phase 2]
Summary
Phase 2 trial exploring genomic markers before and after treatment of actinic keratosis with imiquimod 3.75% cream.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Icahn School of Medicine at Mount Sinai | Conditions: Actinic Keratosis | Phase 2 | Status: COMPLETED | Results posted: 2020-10-20